What is the evidence of genetic factors in the etiology of Graves' disease? A brief review

被引:48
作者
Brix, TH
Kyvik, KO
Hegedus, L
机构
[1] Odense Univ Hosp, Dept Endocrinol M, DK-5000 Odense C, Denmark
[2] Odense Univ, Inst Community Hlth, Genet Epidemiol Res Unit, Odense C, Denmark
关键词
D O I
10.1089/thy.1998.8.627
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Graves' disease (GD) is generally thought of as a multifactorial disorder in which genetic susceptibility interacts with environmental and endogenous factors to cause disease. The importance of genetic factors is suggested by the clustering of GD within families and by a higher concordance rate for disease in monozygotic than in dizygotic twins. This has, however, recently been shown to be less pronounced than previously thought. During the last decade much effort has been put into characterization of the genetic background of GD. Until recently, most studies have examined associations between GD and the human leukocyte antigen (HLA) region, but recent advances in molecular techniques have opened the way for whole genome screening. A number of HLA and non-HLA candidate genes have been proposed, but despite several large investigations within multiplex families no major susceptibility genes have been identified. This brief review discusses relevant articles published from 1940 through 1997 regarding the influence of genetic factors in the etiology of GD. Ongoing studies focus on whole genome screening in multiplex families as well as population-based twin studies. However, the possibility of GD being a heterogeneous disease without a single well-defined genotype and phenotype should be left open.
引用
收藏
页码:627 / 634
页数:8
相关论文
共 86 条
  • [1] ABRAHAM LJ, 1993, CLIN EXP IMMUNOL, V92, P14
  • [2] Association of CTLA-4 gene A-G polymorphism (IDDM12 locus) with acute-onset and insulin-depleted IDDM as well as autoimmune thyroid disease (Graves disease and Hashimoto's thyroiditis) in the Japanese population
    Awata, T
    Kurihara, S
    Iitaka, M
    Takei, S
    Inoue, I
    Ishii, C
    Negishi, K
    Izumida, T
    Yoshida, Y
    Hagura, R
    Kuzuya, N
    Kanazawa, Y
    Katayama, S
    [J]. DIABETES, 1998, 47 (01) : 128 - 129
  • [3] BACH JF, 1993, SPRINGER SEMIN IMMUN, V14, P239
  • [4] TUMOR NECROSIS FACTOR-BETA GENE POLYMORPHISMS IN GRAVES-DISEASE
    BADENHOOP, K
    SCHWARZ, G
    SCHLEUSENER, H
    WEETMAN, AP
    RECKS, S
    PETERS, H
    BOTTAZZO, GF
    USADEL, KH
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1992, 74 (02) : 287 - 291
  • [5] SUSCEPTIBILITY AND RESISTANCE ALLELES OF HUMAN-LEUKOCYTE ANTIGEN (HLA) DQA1 AND HLA DQB1 ARE SHARED IN ENDOCRINE AUTOIMMUNE-DISEASE
    BADENHOOP, K
    WALFISH, PG
    RAU, H
    FISCHER, S
    NICOLAY, A
    BOGNER, U
    SCHLEUSENER, H
    USADEL, KH
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1995, 80 (07) : 2112 - 2117
  • [6] A GENOMIC POINT MUTATION IN THE EXTRACELLULAR DOMAIN OF THE THYROTROPIN RECEPTOR IN PATIENTS WITH GRAVES OPHTHALMOPATHY
    BAHN, RS
    DUTTON, CM
    HEUFELDER, AE
    SARKAR, G
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1994, 78 (02) : 256 - 260
  • [7] Association of HLA-DQA1*0501 with Graves' disease in English Caucasian men and women
    Barlow, ABT
    Wheatcroft, N
    Watson, P
    Weetman, AP
    [J]. CLINICAL ENDOCRINOLOGY, 1996, 44 (01) : 73 - 77
  • [8] BARTELS ED, 1941, THESIS COPENHAGEN, P3
  • [9] HLA ANTIGENS IN GRAVES-DISEASE
    BECH, K
    LUMHOLTZ, B
    NERUP, J
    THOMSEN, M
    PLATZ, P
    RYDER, LP
    SVEJGAARD, A
    SIERSBOEKNIELSEN, K
    MOLHOLMHANSEN, J
    LARSEN, JH
    [J]. ACTA ENDOCRINOLOGICA, 1977, 86 (03): : 510 - 516
  • [10] ASSOCIATION BETWEEN HLA-DR2 AND PRODUCTION OF TUMOR NECROSIS FACTOR-ALPHA AND INTERLEUKIN-1 BY MONONUCLEAR-CELLS ACTIVATED BY LIPOPOLYSACCHARIDE
    BENDTZEN, K
    MORLING, N
    FOMSGAARD, A
    SVENSON, M
    JAKOBSEN, B
    ODUM, N
    SVEJGAARD, A
    [J]. SCANDINAVIAN JOURNAL OF IMMUNOLOGY, 1988, 28 (05) : 599 - 606